secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tengjun Biotechnology Corp. (—)
CIK:        0001499785
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001213900-23-081039
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tengjun Biotechnology removes Caihong Qu as interim CEO/CFO and board member, appoints Ruiming Zhou as CEO & CFO
--------------------------------------------------------------------------------

- Caihong Qu removed as Board member, interim CEO & CFO, appointed Secretary effective Sept 28, 2023.
- Ruiming Zhou, 56, appointed Board member, CEO & CFO, effective Sept 28, 2023.
- Huaping Lu resigned from Board effective Sept 29, 2023; resignation not due to any disagreement.
- Zhou previously served as director at Shandong Tengjunxiang Biotechnology Co., Ltd. since June 2017.
- No transactions or arrangements requiring disclosure under Item 404(a) between Zhou and the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023081039/0001213900-23-081039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023081039/ea186101-8k_tengjun.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-081039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer